Braincells gets US patent cover for treating depression with buspirone

BrainCells Inc, a company leading the scientific research of neurogenesis using its proprietary neural stem cell platform technology to identify novel compounds for the treatment of central nervous system (CNS) diseases, has received the US patent which gives it coverage for treating depression with buspirone, a 5HTR agent, in combination with melatonin, by way of stimulating the formation of …

Visit link:
Braincells gets US patent cover for treating depression with buspirone

Related posts:

1. Companiesandmarkets.com: Depression Therapeutics Market To See Patent Expiries
2. Treating Diabetes, Depression Together May Make Sense
3. Treating depression seen important in heart failure
4. Treating Depressed Moms Helps Kids’ Depression
5. Treating depression: Is there a placebo effect?